Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» vonoprazan
vonoprazan
FDA decision, launch of gastrointestinal drug delayed after nitrosamine found in commercial batches
Endpoints
Wed, 01/4/23 - 10:03 am
Phathom Pharmaceuticals
Takeda
nitrosamine
vonoprazan
FDA
erosive esophagitis
Takeda veterans, Frazier launch Phathom with $90M to develop GI drug vonoprazan
BioCentury
Wed, 05/15/19 - 11:42 pm
Takeda
Frazier Healthcare
Phathom
vonoprazan
gastrointestinal